Drug Database
Back to search

Ireland· IE-PA-PA1235/002/001

Ferrograd C 325mg/500mg Prolonged release Tablets

A ferrous sulfate product containing ferrous sulfate + sodium ascorbate, registered in Ireland by Teofarma S.R.L.. The same ATC class is registered in 10 of our 19 countries.

ATC B03AA07

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedFerrograd C 325mg/500mg Prolonged rel…ATCB03AA07REGISTER NO.IE-PA-PA1235/002/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrous sulfate + sodium ascorbateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ferrous sulfate is registered in 10 of 19 countries.

Countries holding a registration under ATC B03AA07 (ferrous sulfate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose
Search ferrous sulfate products by name

Ferrous sulfate · ATC B03AA07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous sulfate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ferrous sulfate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Ferrous sulfate + Sodium ascorbate
Manufacturer
Teofarma S.R.L.
Country
Ireland (IE)
ATC code
B03AA07
ATC class
Ferrous sulfate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1235/002/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for ferrous sulfate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ferrous sulfate against other medicinesHow interaction checks work

Ferrous sulfate · interactions on record

80 records

  • 3 severe
  • 68 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B03AA07

Ferrous sulfate, as other registers publish it.

All ferrous sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Belgium · Ferograd
  • Luxembourg · Ferograd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0c84abe-2955-484c-b667-499d249603bd
GET /v1/drugs/e0c84abe-2955-484c-b667-499d249603bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "B03AA",
    "B03AA07"
  ],
  "strength": null,
  "pa_number": "PA1235/002/001",
  "substances": [
    "Ferrous sulfate",
    "Sodium ascorbate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1980",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about ferrous sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console